生物标志物 生物标志物
Michele Longoni Calio1,2,3, Luis E Santos4, Amanda Cristina Mosini3
1Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
概括
像GFAP和NfL这样的血清生物标志物可以帮助理解创伤性脑损伤 (TBI) 和阿尔茨海默病 (AD) 之间的联系. 超敏感测量显示这些标记与损伤严重程度和进展相关,有助于个性化诊断.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物发现发现
- 老年学是一门学科.
背景情况:
- 创伤性脑损伤 (TBI) 是已知的阿尔茨海默病 (AD) 的风险因素,但根本机制尚未完全理解.
- 识别神经元和天体细胞损伤的基于血液的生物标志物对于预测神经退行症和实现精准医学至关重要.
- 这项研究调查了血清生物标志物,以探索它们与TBI严重程度,性别特异性反应以及与AD病理学的相关性之间的联系.
研究的目的:
- 使用单分子阵列 (SIMOA) 平台评估血清生物标志物.
- 探索这些生物标志物与TBI严重程度,性别,年龄和受伤后的时间的关联.
- 调查这些生物标志物对AD中发现的神经退行过程的潜在相关性.
主要方法:
- 一个来自III期临床试验 (NCT01048138) 的123名急性TBI患者的亚分析.
- 在多个时间点使用SIMOA分析血清样本,以检测包括Tau,NfL,GFAP和UCHL1在内的生物标志物.
- 生物标志物概况在治疗组之间进行了比较,包括TBI严重程度,性别,年龄和受伤后的时间,并对AD相关性的额外分析.
主要成果:
- GFAP和NfL与年龄,性别,TBI严重程度和时间进展有很强的相关性,表明了星系细胞和轴突损伤.
- UCHL1水平也与创伤严重程度,性别和受伤后的时间有关,尽管不如NfL和GFAP那么显著.
- 观察到性别特异性差异,女性的Tau,GFAP和UCHL1水平较高,但NfL水平较低. 老年患者表现出NfL和GFAP的增加.
结论:
- 血清生物标志物GFAP和NfL在阐明TBI和AD之间的分子联系方面显示出希望.
- SIMOA技术允许精确量化,为TBI-to-AD时间表和长期神经退行提供了洞察力.
- 这些发现支持个性化的诊断方法和治疗监测TBI和AD.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516